Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells
- DOI
- 10.1007/s00280-023-04624-6
- Published
- 2024-01-16
- Container
- Cancer Chemotherapy and Pharmacology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-023-04624-6,
title = {Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells},
author = {Thamir M. Mahgoub and Emmet J. Jordan and Amira F. Mahdi and Veronika Oettl and Stefanie Huefner and Norma O’Donovan and John Crown and Denis M. Collins},
year = {2024},
journal = {Cancer Chemotherapy and Pharmacology},
doi = {10.1007/s00280-023-04624-6},
url = {https://doi.org/10.1007/s00280-023-04624-6}
}RIS
TY - JOUR TI - Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells AU - Thamir M. Mahgoub AU - Emmet J. Jordan AU - Amira F. Mahdi AU - Veronika Oettl AU - Stefanie Huefner AU - Norma O’Donovan AU - John Crown AU - Denis M. Collins PY - 2024 JO - Cancer Chemotherapy and Pharmacology DO - 10.1007/s00280-023-04624-6 UR - https://doi.org/10.1007/s00280-023-04624-6 ER -
APA
Mahgoub, T. M., Jordan, E. J., Mahdi, A. F., Oettl, V., Huefner, S., O’Donovan, N., Crown, J., & Collins, D. M. (2024). Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-023-04624-6
Source records
- crossref · retrieved 2026-09-26T07:55:44.591Z